Electrophysiological Signature of Mild Cognitive Impairment and Its Relationship with Parkinson's Disease: a High-density EEG Investigation

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The study aims to investigate neural correlate of Mild Cognitive Impairment (MCI) in Parkinson's disease (PD) and to identify a link between functional impairment (in both cognitive and motor domains) and electrophysiological cortical sing of MCI in PD. A sample of 42 subjects will be divide into three subgroup: healthy control, PD with MCI (PD-MCI) and PD without MCI (PD-ctrl). Those subjects will undergo a specific neuropsychological evaluation and, to measure the electro-cortical activity, high-density electroencephalography (hdEEG) will be record during both resting state and cognitive tasks. Furthermore, hdEEG data will be combine with structural magnetic resonance to obtain information about network connectivity.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 90
Healthy Volunteers: t
View:

• Upper score \>24 MMSE or \>15.5 Moca

• If taking medications, taking stable doses for at least 4 weeks prior to the inclusion visit - of anticholinesterase drugs (donepezil, memantine, rivastigmine, ...) or antidepressants (SSRIs, tricyclics, SNARI, ...) or Levodopa.

• Having signed the informed consent

Locations
Other Locations
Italy
IRCCS San Camillo S.R.L
RECRUITING
Lido
Contact Information
Primary
Francesca Burgio, PhD
francesca.burgio@hsancamillo.it
+390412207536
Backup
Giovanni Lazzaro, MSc
giovanni.lazzaro@hsancamillo.it
+3904122079598
Time Frame
Start Date: 2023-06-18
Estimated Completion Date: 2025-05
Participants
Target number of participants: 42
Treatments
PD-MCI
Parkinson's disease with Mild Cognitive Impairment
PD-nMCI
Parkinson's disease without Mild Cognitive Impairment
Healthy control
Healthy participants matched for age and gender with the experimental groups
Related Therapeutic Areas
Sponsors
Leads: IRCCS San Camillo, Venezia, Italy

This content was sourced from clinicaltrials.gov